Enteric infection with Citrobacter rodentium induces coagulative liver necrosis and hepatic inflammation prior to peak infection and colonic disease

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Raczynski, Arkadiusz R ^a   Muthupalani, Sureshkumar ^b   Schlieper, Katherine ^a   Fox, James G ^a,b   Tannenbaum, Steven R ^a   Schauer, David B ^a,b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CITROBACTER RODENTIUM; CLINICAL FEATURE; COLON DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENTEROBACTERIACEAE INFECTION; FEMALE; HEPATITIS; HISTOPATHOLOGY; HOST PATHOGEN INTERACTION; HYPERTRANSAMINASEMIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; INTESTINE INFECTION; LIVER ISCHEMIA; LIVER NECROSIS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PREDICTION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SYNDROME DELINEATION; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; C57BL MOUSE; LIVER; MICROBIOLOGY; NECROSIS; NONPARAMETRIC TEST; PATHOLOGY; PHYSIOLOGY;

ANIMALIA; BACTERIA (MICROORGANISMS); CITROBACTER RODENTIUM; MUS;

CHEMOKINE; CYTOKINE;

ANALYSIS OF VARIANCE; ANIMALS; CHEMOKINES; CITROBACTER RODENTIUM; COLONIC DISEASES; CYTOKINES; HEPATITIS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIVER; MICE; MICE, INBRED C57BL; NECROSIS; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC;

EID: 84857972808     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033099     Document Type: Article

References (46)

1. Choi S, Diehl AM, (2005) Role of inflammation in nonalcoholic steatohepatitis. Curr Opin Gastroenterol 21: 702-707.
2. Tilg H, Moschen AR, (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52: 1836-1846.
3. Jaeschke H, (2006) Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol 290: G1083-1088.
4. Kato A, Yoshidome H, Edwards MJ, Lentsch AB, (2000) Reduced hepatic ischemia/reperfusion injury by IL-4: potential anti-inflammatory role of STAT6. Inflamm Res 49: 275-279.
5. Roth RA, Harkema JR, Pestka JP, Ganey PE, (1997) Is exposure to bacterial endotoxin a determinant of susceptibility to intoxication from xenobiotic agents? Toxicol Appl Pharmacol 147: 300-311.
6. Roth RA, Luyendyk JP, Maddox JF, Ganey PE, (2003) Inflammation and drug idiosyncrasy-is there a connection? J Pharmacol Exp Ther 307: 1-8.
7. Janeway CA Jr, Medzhitov R, (2002) Innate immune recognition. Annu Rev Immunol 20: 197-216.
8. Crispe IN, (2009) The liver as a lymphoid organ. Annu Rev Immunol 27: 147-163.
9. Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S, (2005) Citrobacter rodentium of mice and man. Cell Microbiol 7: 1697-1706.
10. Luperchio SA, Schauer DB, (2001) Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect 3: 333-340.
11. Borenshtein D, McBee ME, Schauer DB, (2008) Utility of the Citrobacter rodentium infection model in laboratory mice. Curr Opin Gastroenterol 24: 32-37.
12. Richardson TA, Sherman M, Antonovic L, Kardar SS, Strobel HW, et al. (2006) Hepatic and renal cytochrome p450 gene regulation during citrobacter rodentium infection in wild-type and toll-like receptor 4 mutant mice. Drug Metab Dispos 34: 354-360.
13. Richardson TA, Sherman M, Kalman D, Morgan ET, (2006) Expression of UDP-glucuronosyltransferase isoform mRNAs during inflammation and infection in mouse liver and kidney. Drug Metab Dispos 34: 351-353.
14. Morgan ET, Goralski KB, Piquette-Miller M, Renton KW, Robertson GR, et al. (2008) Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos 36: 205-216.
15. Wiles S, Clare S, Harker J, Huett A, Young D, et al. (2004) Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell Microbiol 6: 963-972.
16. Vallance BA, Deng W, Jacobson K, Finlay BB, (2003) Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect Immun 71: 3443-3453.
17. McBee ME, Zheng PZ, Rogers AB, Fox JG, Schauer DB, (2008) Modulation of acute diarrheal illness by persistent bacterial infection. Infect Immun 76: 4851-4858.
18. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, et al. (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14: 282-289.
19. Higgins LM, Frankel G, Douce G, Dougan G, MacDonald TT, (1999) Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect Immun 67: 3031-3039.
20. McBee ME, Zeng Y, Parry N, Nagler CR, Tannenbaum SR, et al. (2010) Multivariate modeling identifies neutrophil- and Th17-related factors as differential serum biomarkers of chronic murine colitis. PLoS One 5: e13277.
21. Deitch EA, Berg R, Specian R, (1987) Endotoxin promotes the translocation of bacteria from the gut. Arch Surg 122: 185-190.
22. Asfaha S, MacNaughton WK, Appleyard CB, Chadee K, Wallace JL, (2001) Persistent epithelial dysfunction and bacterial translocation after resolution of intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 281: G635-644.
23. Ghaem-Maghami M, Simmons CP, Daniell S, Pizza M, Lewis D, et al. (2001) Intimin-specific immune responses prevent bacterial colonization by the attaching-effacing pathogen Citrobacter rodentium. Infect Immun 69: 5597-5605.
24. Flynn AN, Buret AG, (2008) Tight junctional disruption and apoptosis in an in vitro model of Citrobacter rodentium infection. Microb Pathog 45: 98-104.
25. Zhang Q, Li Q, Wang C, Liu X, Li N, et al. (2010) Enteropathogenic Escherichia coli changes distribution of occludin and ZO-1 in tight junction membrane microdomains in vivo. Microb Pathog 48: 28-34.
26. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, et al. (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13: 1324-1332.
27. Thompson PA, Gauthier KC, Varley AW, Kitchens RL, (2010) ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance. J Lipid Res 51: 2672-2685.
28. Rajani R, Bjornsson E, Bergquist A, Danielsson A, Gustavsson A, et al. (2010) The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther 32: 1154-1162.
29. Luyendyk JP, Maddox JF, Green CD, Ganey PE, Roth RA, (2004) Role of hepatic fibrin in idiosyncrasy-like liver injury from lipopolysaccharide-ranitidine coexposure in rats. Hepatology 40: 1342-1351.
30. Jones SA, (2005) Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 175: 3463-3468.
31. McLoughlin RM, Witowski J, Robson RL, Wilkinson TS, Hurst SM, et al. (2003) Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J Clin Invest 112: 598-607.
32. Fielding CA, McLoughlin RM, McLeod L, Colmont CS, Najdovska M, et al. (2008) IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. J Immunol 181: 2189-2195.
33. Feng D, Wang Y, Xu Y, Luo Q, Lan B, et al. (2009) Interleukin 10 deficiency exacerbates halothane induced liver injury by increasing interleukin 8 expression and neutrophil infiltration. Biochem Pharmacol 77: 277-284.
34. Bourdi M, Eiras DP, Holt MP, Webster MR, Reilly TP, et al. (2007) Role of IL-6 in an IL-10 and IL-4 double knockout mouse model uniquely susceptible to acetaminophen-induced liver injury. Chem Res Toxicol 20: 208-216.
35. Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, et al. (2002) Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 35: 289-298.
36. Fuentes ME, Durham SK, Swerdel MR, Lewin AC, Barton DS, et al. (1995) Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 155: 5769-5776.
37. Chaluvadi MR, Kinloch RD, Nyagode BA, Richardson TA, Raynor MJ, et al. (2009) Regulation of hepatic cytochrome P450 expression in mice with intestinal or systemic infections of citrobacter rodentium. Drug Metab Dispos 37: 366-374.
38. Son G, Kremer M, Hines IN, (2010) Contribution of gut bacteria to liver pathobiology. Gastroenterol Res Pract 2010.
39. Douglas DB, Beiting DP, Loftus JP, Appleton JA, Bliss SK, (2010) Combinatorial effects of interleukin 10 and interleukin 4 determine the progression of hepatic inflammation following murine enteric parasitic infection. Hepatology 51: 2162-2171.
40. Saraiva M, O'Garra A, (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170-181.
41. Gabele E, Dostert K, Hofmann C, Wiest R, Scholmerich J, et al. (2011) DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J Hepatol 55: 1391-1399.
42. Fox JG, Li X, Yan L, Cahill RJ, Hurley R, et al. (1996) Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis. Infect Immun 64: 1548-1558.
43. Fox JG, Dewhirst FE, Tully JG, Paster BJ, Yan L, et al. (1994) Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol 32: 1238-1245.
44. Fox JG, Ge Z, Whary MT, Erdman SE, Horwitz BH, (2011) Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer. Mucosal Immunol 4: 22-30.
45. Garrett WS, Gordon JI, Glimcher LH, (2010) Homeostasis and inflammation in the intestine. Cell 140: 859-870.
46. Borenshtein D, Nambiar PR, Groff EB, Fox JG, Schauer DB, (2007) Development of fatal colitis in FVB mice infected with Citrobacter rodentium. Infect Immun 75: 3271-3281.